Management of a Thrombus in a Dolichoectatic Basilar Artery Secondary to Fabry Disease

被引：1
|
作者：
Mak, Gloria [1 ]
Philip, Anemon Puthuppallil [1 ]
Perera, Kanjana [2 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Populat Hlth Res Inst, Dept Med, Hamilton, ON, Canada
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2023年 / 50卷 / 01期
关键词：
Cerebrovascular disease/stroke; Stroke in young adults; Fabry disease; Intracranial arterial dolichoectasia;
D O I：
10.1017/cjn.2021.250
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：149 / 151
页数：3
相关论文
共 50 条
  • [41] Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel
    Stepien, Karolina. M. M.
    Broomfield, Alexander
    Cole, Duncan
    Deegan, Patrick. B. B.
    Forshaw-Hulme, Stuart
    Hughes, Derralynn
    Jovanovic, Ana
    Morris, Liz
    Muir, Alison
    Ramaswami, Uma
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [42] Clinical Characteristics of the GLA N215S Variant and Implications for the Diagnosis and Management of Nonclassic Fabry Disease
    Reuter, Chloe
    Platt, Julia
    CIRCULATION-CARDIOVASCULAR GENETICS, 2017, 10 (05)
  • [43] Fabry disease and COVID-19: international expert recommendations for management based on real-world experience
    Laney, Dawn A.
    Germain, Dominique P.
    Oliveira, Joao Paulo
    Burlina, Alessandro P.
    Horacio Cabrera, Gustavo
    Hong, Geu-Ru
    Hopkin, Robert J.
    Niu, Dau-Ming
    Thomas, Mark
    Trimarchi, Hernan
    Wilcox, William R.
    Manuel Politei, Juan
    Ortiz, Alberto
    CLINICAL KIDNEY JOURNAL, 2020, 13 (06) : 913 - 925
  • [44] The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry Disease
    Limgala, Renuka P.
    Fikry, Jaqueline
    Veligatla, Vasudha
    Goker-Alpan, Ozlem
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 10
  • [45] Fabry disease management: Current status, therapeutic challenges, and future horizons in drug delivery and artificial intelligence assisted diagnosis
    Raj, Alan
    Sajayan, Krishnameera
    Chandran, C. Sarath
    Alex, Angel Treasa
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 100
  • [46] Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN)
    Helena Vaisbich, Maria
    Modelli de Andrade, Luis Gustavo
    Braga Silva, Cassiano Augusto
    Barreto, Fellype de Carvalho
    JORNAL BRASILEIRO DE NEFROLOGIA, 2022, 44 (02): : 268 - 280
  • [47] Humoral Immune Response to SARS-CoV-2 Vaccination after a Booster Vaccine Dose in Two Kidney Transplant Recipients with Fabry Disease and Variable Secondary Immunosuppressive Regimens
    Bernea, Lavinia
    Ailioaie, Oana R.
    Benhamouda, Nadine
    Tartour, Eric
    Germain, Dominique P.
    VACCINES, 2021, 9 (12)
  • [48] Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents
    Berry, Lisa
    Walter, Jerry
    Johnson, Jack
    Alton, Julia
    Powers, Janet
    Lloria, Xavier
    Koulinska, Irene
    McGee, Meghan
    Laney, Dawn
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [49] Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R)
    Keisuke Suzuki
    Naoto Miura
    Wataru Kitagawa
    Shinkichi Suzuki
    Atsushi Komatsuda
    Kazuhiro Nishikawa
    Daisuke Watanabe
    Hirokazu Imai
    Clinical and Experimental Nephrology, 2011, 15 : 916 - 920
  • [50] Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R)
    Suzuki, Keisuke
    Miura, Naoto
    Kitagawa, Wataru
    Suzuki, Shinkichi
    Komatsuda, Atsushi
    Nishikawa, Kazuhiro
    Watanabe, Daisuke
    Imai, Hirokazu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (06) : 916 - 920
12345